Recombinant RSV (Palivizumab Biosimilar) antibody

Catalog No. ABIN7795088

This Humanized Monoclonal antibody specifically detects RSV (Palivizumab Biosimilar) in FACS and in vivo. It exhibits reactivity toward Human.

Quick Overview for Recombinant RSV (Palivizumab Biosimilar) antibody (ABIN7795088)

Target: RSV (Palivizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This RSV (Palivizumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade: Research Grade

Product Details anti-RSV (Palivizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Palivizumab Biosimilar, Endotoxin 0.05 EU/mg

Characteristics: Palivizumab, a humanized anti-RSV (respiratory syncytial virus) monoclonal antibody, targets an epitope in the A antigenic site of the F protein of RSV, inhibiting its entry into the cell and thereby preventing infection.

Purification: Protein A or G affinity column

Purity: >95 % by reducing SDS-PAGE

Endotoxin Level: Less than 0.5 EU/mg of protein as determined by LAL method

Immunogen: Respiratory Syncytial Virus F protein

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: > 3 mg/mL

Storage: 4 °C,-20 °C

Storage Comment: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Target Details for RSV (Palivizumab Biosimilar)

Target: RSV (Palivizumab Biosimilar)

Alternative Name: Palivizumab Biosimilar

Target Type: Biosimilar